NewsTARGET PharmaSolutions Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) ResearchRead more →Read more →
NewsTARGET PharmaSolutions to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead SciencesRead more →Read more →
TARGET PharmaSolutions Announces Partnership with Bristol Myers Squibb to Advance Inflammatory Bowel Disease (IBD) ResearchRead more →
TARGET PharmaSolutions to Advance Research in NASH and Hepatitis B Through New Collaboration with Gilead SciencesRead more →
Intercept (ICPT) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASHRead more →
Bristol-Myers Squibb (BMY) Extends Strategic Partnership with TARGET PharmaSolutions for TARGET-NASHRead more →
TARGET PharmaSolutions Partners with Bristol-Myers Squibb, Offering a New Platform to Collect Real World DataRead more →
Intercept Announces OCALIVA (OBETICHOLIC ACID) Data in PBC to be Presented at the 2016 AASLD Annual MeetingRead more →
